In8bio (INAB) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

INAB In8bio

Watchlist

0.271
+0.041+17.77%

Close Oct 18 16:00 ET

0.273
+0.002+0.85%

Post 19:57 ET

19.66MMarket Cap-330P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Aigh Capital Management, LLC Reports 9.3% Passive Stake in IN8bio, Inc. as of Oct 1
ReutersOct 9 17:21 ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
BenzingaOct 8 16:31 ET
Q3 Pharma and Biotech Layoffs in Charts: More Than 1000 Each in July and August
Seeking AlphaOct 4 14:02 ET
Express News | Watching IN8bio; Zacks Small-Cap Research Gives Stock $1.50 Price Valuation
BenzingaOct 2 11:04 ET
IN8BIO INAB Private Placement; Cardio Diagnostics CDIO Pricing Determinations
BioPharmCatalystOct 2 08:16 ET
Express News | IN8bio, Inc. - Units Sold at $0.395 per Unit
ReutersOct 1 08:01 ET

Comments

Stock_Drift

Oct 14 07:09

Pre Market Ticks. 8:07am 10/14

$Destiny Tech100 (DXYZ.US)$ $Vanda Pharmaceuticals (VNDA.US)$ $In8bio (INAB.US)$ $Rani Therapeutics (RANI.US)$ $Jasper Therapeutics (JSPR.US)$ $B Riley Financial Inc 7.5% Sr Nts 31/05/2027 Usd25 (RILYZ.US)$ $B. Riley Financial Inc (RILYP.US)$ $B Riley Financial Inc 6.375% Senior Notes Due 2025 (RILYM.US)$ $B. Riley Financial (RILY.US)$ $Longboard Pharmaceuticals (LBPH.US)$ $Expion360 (XPON.US)$ $Inventiva (IVA.US)$ $Tevogen Bio Holdings (TVGN.US)$

Trytosaveabit

Oct 11 18:51

New Form 13!

$In8bio (INAB.US)$ In8bio | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BIOS CAPITAL MANAGEMENT, LP(23.1%),BIOS ADVISORS GP, LLC(23.1%), etc.
SEC· 18:04

Trytosaveabit

Oct 9 16:26

Update

$In8bio (INAB.US)$ In8bio | SC 13G: Statement of acquisition of beneficial ownership by individuals-AIGH Capital Management, LLC(9.3%),Orin H(9.3%)
SEC· 3 mins ago

Trytosaveabit

Oct 2 03:17

PP filed 8K last evening

$In8bio (INAB.US)$ On September 30, 2024, In8bio, Inc. announced the entry into a Securities Purchase Agreement with certain investors for a private placement. The agreement involves the sale of approximately 25.76 million shares of common stock, 5.65 million pre-funded warrants, and 31.41 million Series C warrants, generating initial gross proceeds of around $12.4 million. This capital is intended to support the company's operations into 2026. The pre-funded warrants have...